EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structure and Dynamics of Three Escherichia coli NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954

Martin A Day, Andrew J Christofferson, J L Ross Anderson, Simon O Vass, Adam Evans, Peter F Searle, Scott A White, Eva I Hyde

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24065987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Martin A Day und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Prodrugs, Neoplasms, Escherichia coli Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Escherichia coli NfsB has been studied extensively for its potential for cancer gene therapy by reducing the prodrug CB1954 to a cytotoxic derivative. We have previously made several mutants with enhanced activity for the prodrug and characterised their activity in vitro and in vivo. Here, we determine the X-ray structure of our most active triple and double mutants to date, T41Q/N71S/F124T and T41L/N71S. The two mutant proteins have lower redox potentials than wild-type NfsB, and the mutations have lowered activity with NADH so that, in contrast to the wild-type enzyme, the reduction of the enzyme by NADH, rather than the reaction with CB1954, has a slower maximum rate. The structure of the triple mutant shows the interaction between Q41 and T124, explaining the synergy between these two mutations. Based on these structures, we selected mutants with even higher activity. The most active one contains T41Q/N71S/F124T/M127V, in which the additional M127V mutation enlarges a small channel to the active site. Molecular dynamics simulations show that the mutations or reduction of the FMN cofactors of the protein has little effect on its dynamics and that the largest backbone fluctuations occur at residues that flank the active site, contributing towards its broad substrate range.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplasmsEscherichia coli ProteinsHumansEscherichia coliNADOxidoreductasesNitroreductasesAziridines

Stichwörter der Autor:innen

CB1954NfsBflavoproteinmolecular dynamicsnitroreductaseprodrug

Substanzen

ProdrugsNADOxidoreductasesNitroreductasesEscherichia coli ProteinstretazicarAziridinesNfsB protein, E coli

Autor:innen und Institutionen

  • School of Biosciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • School of Science, RMIT University, Melbourne, VIC 3000, Australia.
  • School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.

Förderung

  • NIGMS NIH HHS
  • Medical Research Council

Zitieren

APA

Day, M. A., Christofferson, A. J., Anderson, J. L. R., Vass, S. O., Evans, A., Searle, P. F., White, S. A., & Hyde, E. I. (2023). Structure and Dynamics of Three Escherichia coli NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065987

Vancouver

Day MA, Christofferson AJ, Anderson JLR, Vass SO, Evans A, Searle PF, et al. Structure and Dynamics of Three Escherichia coli NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065987

BibTeX
@article{Day2023,
  author = {Day, Martin A and Christofferson, Andrew J and Anderson, J L Ross and Vass, Simon O and Evans, Adam and Searle, Peter F and White, Scott A and Hyde, Eva I},
  title = {Structure and Dynamics of Three Escherichia coli NfsB Nitro-Reductase Mutants Selected for Enhanced Activity with the Cancer Prodrug CB1954},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24065987}
}
Kostenlos starten →